Investment Philosophy
Our investment philosophy is to seek out and invest in companies that possess exceptional management teams, have an opportunity to become market leaders in their categories and whose greatest potential for growth lies ahead of them. We invest thematically, focusing our time and effort on developing deep domain expertise in any sector where we invest. We will invest in companies at the seed stage, to later stage companies with more established businesses. More specifically, in life sciences we invest in companies developing therapeutics that address significant unmet medical needs, with a well defined mechanism of action, and clinical and regulatory strategy. In technology, we focus on disruptive business models and technologies in sectors where we possess unique insights and domain expertise. We typically will invest anywhere between $6 million to $18 million over the life of a company.
Over the years, Panorama Capital has adopted a collaborative, team-oriented investment culture. Unlike other multi-sector venture capital funds with separate teams responsible for their specific sector portfolio, we manage life sciences and technology investments as one portfolio and actively collaborate on all investment decisions. Representative past investments in life sciences include Corus Pharmaceuticals, Eyetech, Myogen, and Praecis. In technology, our past investments include companies such as Yipes Enterprise Services, Portal Player, Kinko's, Seagate, ONI Systems, Digital Island, Juniper Networks, Abatis Systems, and Fastlane Technologies.